{
    "title": "AbbVie-Allergan $63 bln deal aided by Nestle, AstraZeneca buys",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7933551/AbbVie-Allergan-63-bln-deal-aided-Nestle-AstraZeneca-buys.html",
    "date": "2020-01-27",
    "keywords": [
        "medicine",
        "product",
        "development",
        "company",
        "portfolio",
        "food",
        "business",
        "miller",
        "allergan",
        "treatment",
        "drug",
        "nutrition",
        "takeover",
        "astrazeneca",
        "disease",
        "colitis",
        "executive",
        "deal",
        "opportunity",
        "head",
        "statement",
        "brazikumab",
        "return",
        "tieup",
        "help",
        "buying",
        "control",
        "wrinkle",
        "botox",
        "expiration",
        "group",
        "nestle",
        "zuercher",
        "kantonalbank",
        "vevey",
        "commission",
        "month",
        "immunology",
        "risk",
        "progress",
        "completion",
        "acquisition",
        "gonzalez",
        "chairman",
        "chance",
        "stock",
        "mark",
        "schneider",
        "viokace",
        "enzyme",
        "growth",
        "mainstream",
        "health",
        "science",
        "astrazenecas",
        "pact",
        "inflammation",
        "astra",
        "licensing",
        "creation",
        "companion",
        "agreement",
        "programme",
        "option",
        "mene",
        "pangalos",
        "research",
        "bill",
        "part",
        "start",
        "market",
        "note",
        "john",
        "burger",
        "frankfurt",
        "editing",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}